Photo-Inactivation of

Viviana Teresa Orlandi, Eleonora Martegani, Nicola Trivellin, Fabrizio Bolognese, Enrico Caruso

Open access · goldAbstract read

In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 32% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.Molecules (Basel, Switzerland) · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Viviana Teresa OrlandiDepartment of Biotechnologies and Life Sciences, University of Insubria, Via J.H. Dunant 3, 21100 Varese, Italy.ORCID 0000-0001-6010-2840

Eleonora MarteganiDepartment of Biotechnologies and Life Sciences, University of Insubria, Via J.H. Dunant 3, 21100 Varese, Italy.ORCID 0000-0002-8103-686X

Nicola TrivellinDepartment of Industrial Engineering, University of Padova, Via Gradenigo 6A, 35131 Padova, Italy.

Fabrizio BologneseDepartment of Biotechnologies and Life Sciences, University of Insubria, Via J.H. Dunant 3, 21100 Varese, Italy.

Enrico CarusoDepartment of Biotechnologies and Life Sciences, University of Insubria, Via J.H. Dunant 3, 21100 Varese, Italy.ORCID 0000-0002-6700-911X

University of Insubria · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic Antimicrobial Chemotherapy (PACT) has received great attention in recent years since it is an effective and promising modality for the treatment of human oral and skin infections with the advantage of bypassing pathogens' resistance to antimicrobials. Moreover, PACT applications demonstrated a certain activity in the inhibition and eradication of biofilms, overcoming the well-known tolerance of sessile communities to antimicrobial agents. In this study, 13 diaryl-porphyrins (mono-, di-cationic, and non-ionic)

Indexed as

diaryl-porphyrinsPhotodynamic Antimicrobial Chemotherapy (PACT)Staphylococcus aureus

Identifiers

PMID36830139

DOI10.3390/antibiotics12020228

PMCPMC9951968

OpenAlexW4317933341

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.